A

Alkermes plc
D

ALKS

28.790
USD
-0.20
(-0.69%)
مغلق
حجم التداول
39,087
الربح لكل سهم
1
العائد الربحي
-
P/E
14
حجم السوق
4,747,507,995
أصول ذات صلة
ABBV
ABBV
-1.530
(-0.80%)
189.200 USD
AZN
AZN
-1.530
(-2.15%)
69.590 USD
BMY
BMY
-0.525
(-1.10%)
47.080 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
JNJ
JNJ
0.570
(0.37%)
156.110 USD
LLY
LLY
0.55
(0.07%)
779.65 USD
MRK
MRK
-1.370
(-1.66%)
81.010 USD
NVS
NVS
-1.350
(-1.09%)
122.490 USD
PFE
PFE
0.110
(0.43%)
25.440 USD
SNY
SNY
-0.990
(-2.01%)
48.310 USD
TEVA
TEVA
-0.045
(-0.26%)
17.010 USD
المزيد
الأخبار المقالات

العنوان: Alkermes plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.